Analysis of Clinicopathologic Features and Imaging Findings of TFE3-Rearranged Renal Cell Carcinoma
Clinical Genitourinary Cancer · 2025
DOI: 10.1016/j.clgc.2025.102446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2025. Verfasst von Jianqiang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Lanzhou University Second Hospital, Lanzhou 730000, China; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou 7300…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
OBJECTIVE: To examine the imaging features and clinicopathologic features of TFE3-rearranged renal cell carcinoma and highlight key imaging findings for clinical decision-making. METHODS: The imaging and clinicopathological data of 49 pathologically confirmed cases of TFE3-rearranged renal cell carcinoma from multiple institutions between January 2018 and December 2024 were retrospectively analyzed. RESULTS: Of the 49 patients, 17 were male and 32 were female; aged 44 ± 15 years (range: 10-82 years) , 22 were asymptomatic and 27 were symptomatic. Tumor size averaged 7.0 (range: 2.0-14.9) cm. Imaging showed 28 round-like and 21 lobulated lesions; 18 had distinct margins, while 31 had indistinct margins. A pseudocapsule was present in 36 cases, 24 of which were incomplete. Additionally, 42 tumors showed uneven density with necrosis or cystic degeneration; there were 25 cases of hemorrhage, 27 cases of irregular calcification, Peritumoral vessels were noted in 23 cases. Imaging modalities included CT (44 cases: 41 with both plain and enhanced scans, 3 with plain only), MRI (13 cases with plain and enhanced scans), and ultrasonography (15 cases, including 5 with contrast enhancement). Treatment included partial nephrectomy (21 cases), total nephrectomy (22 cases) , and biopsy (6 cases).With a median follow-up of 30 months (range: 1-72 months) until December 2024, 6 patients experienced tumor recurrence, 14 developed metastasis, and 7 died, while 5 patients were lost to follow-up. CONCLUSION: TFE3-rearranged renal cell carcinoma is a rare renal tumor with distinct imaging and clinical features that can inform preoperative diagnosis, treatment, and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou 730000, China; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou 730000, China; Second Clinical School, Lanzhou University, Lanzhou 730000,…
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou 730000, China; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou 730000, China; Gansu International Scientific and Technological Cooperatio…
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou 730000, China; Department of Radiology, Lanzhou University First Hospital, Lanzhou, Lanzhou 730000, China. Electronic address: wanggangldyy@163.com.
Förderung
- Natural Science Foundation of Gansu Province
Zitieren
APA
Liu, J., Wei, J., Zhang, Y., Han, S., Zhang, Q., Hu, E., Sun, X., Wang, G., & Zhao, J. (2025). Analysis of Clinicopathologic Features and Imaging Findings of TFE3-Rearranged Renal Cell Carcinoma. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2025.102446
Vancouver
Liu J, Wei J, Zhang Y, Han S, Zhang Q, Hu E, et al. Analysis of Clinicopathologic Features and Imaging Findings of TFE3-Rearranged Renal Cell Carcinoma. Clinical Genitourinary Cancer. 2025. doi:10.1016/j.clgc.2025.102446
BibTeX
@article{Liu2025,
author = {Liu, Jianqiang and Wei, Jinyan and Zhang, Yuting and Han, Sitong and Zhang, Qi and Hu, Enbo and Sun, Xuejian and Wang, Gang and Zhao, Jianhong},
title = {Analysis of Clinicopathologic Features and Imaging Findings of TFE3-Rearranged Renal Cell Carcinoma},
journal = {Clinical Genitourinary Cancer},
year = {2025},
doi = {10.1016/j.clgc.2025.102446}
}
EUVIMED